Common use of By deCODE Clause in Contracts

By deCODE. For a Disease, commencing at the end of the Research Program for such Disease, and until the first registration of a deCODE Product in any Major Country, within sixty (60) days after the end of each calendar year, provide written summary of Commercially Reasonable Efforts and provided deCODE determines not to develop Shelved Products for the Disease directly or through an Affiliate, deCODE shall provide to Roche a written summary of: (i) deCODE's and its Affiliates' efforts to identify and obtain a licensee for Shelved Products for the Disease, -39- 48 and (ii) the Sublicensee's Required Efforts of deCODE's licensees in the Major Countries during such previous year; provided that deCODE is permitted by such sublicensee to share such information with Roche. All such summaries shall be treated by Roche as Confidential Information under Section 13.

Appears in 1 contract

Sources: Collaboration and Cross License Agreement (Decode Genetics Inc)

By deCODE. For a Selected Disease, commencing at the end of the Research Program for such Selected Disease, and until the first registration of a deCODE Product in any Major Country, within sixty (60) days after the end of each calendar year, provide written summary of Commercially Reasonable Efforts and provided deCODE determines not to develop Shelved deCODE Products for the Selected Disease directly or through an Affiliate, deCODE shall provide to Roche a written summary of: (i) deCODE's and its Affiliates' efforts to identify and obtain a licensee for Shelved deCODE Products for the Selected Disease, -39- 48 and (ii) the Sublicensee's Required Efforts of deCODE's licensees in the Major Countries during such previous year; provided that deCODE is permitted by such sublicensee to share such information with Roche. All such summaries shall be treated by Roche as Confidential Information under Section 13.

Appears in 1 contract

Sources: Research Collaboration and Cross License Agreement (Decode Genetics Inc)